ClinConnect ClinConnect Logo
Search / Trial NCT06528587

Rehabilitation of Single Aesthetic Areas Using Narrow Diameter Implants

Launched by FONDAZIONE POLICLINICO UNIVERSITARIO AGOSTINO GEMELLI IRCCS · Jul 26, 2024

Trial Information

Current as of June 26, 2025

Not yet recruiting

Keywords

Narrow Diameter Implant

ClinConnect Summary

This clinical trial is investigating the use of narrow diameter dental implants to help patients who have lost a single tooth in the front part of their mouth, especially those with less bone thickness or limited space. The goal is to find a simpler and less invasive way to restore these patients' smiles without needing more complicated treatments. While there is not much research on this topic, the trial aims to gather important information about how effective these narrow implants can be.

To participate in this study, you should be an adult over 18 years old, a non-smoker or someone who smokes only a few cigarettes a day, and generally healthy (classified as ASA I or II, which means you have no major health issues). You'll need to sign a consent form to show you understand the study. If you have certain medical conditions, such as severe diseases or uncontrolled diabetes, or if you're pregnant or breastfeeding, you may not be eligible to join. Participants will receive careful follow-up throughout the study to monitor their progress and ensure their safety.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Patients who have undergone implant surgery to perform implant rehabilitation of single edentulism in the anterior region to insert a reduced diameter implant;
  • ASA I and ASA II patients;
  • Age \> 18yr;
  • Non-smokers or smokers ≤ 5 cig/day;
  • Achievement of FMPS and FMBS ≤ 15%;
  • Signing of the written informed consent to participate in the study.
  • Exclusion Criteria:
  • Severe general medical pathologies;
  • Immunodeficiency states;
  • Radiotherapy in the head and neck region;
  • Uncontrolled diabetes or hypertension;
  • Smokers \>5 cigs/day;
  • Impossibility to carry out homogeneous and continuous follow-up;
  • Documented allergy to the biomaterials used;
  • Pregnancy or breastfeeding;
  • Inability to provide written informed consent.

About Fondazione Policlinico Universitario Agostino Gemelli Irccs

Fondazione Policlinico Universitario Agostino Gemelli IRCCS is a leading research and healthcare institution based in Rome, Italy, renowned for its commitment to advancing medical science and improving patient care. As a prominent academic medical center affiliated with the Catholic University of the Sacred Heart, it integrates clinical practice, education, and research, fostering innovation in various fields of medicine. The foundation conducts a wide range of clinical trials aimed at developing new therapies and enhancing treatment protocols, with a focus on translational research that bridges the gap between laboratory discoveries and patient care. Its multidisciplinary approach and dedication to high ethical standards position it as a key player in the landscape of clinical research and healthcare improvement in Italy and beyond.

Locations

Rome, Roma, Italy

Patients applied

0 patients applied

Trial Officials

Paolo Francesco Manicone

Principal Investigator

Fondazione Policlinico Universitario A. Gemelli, IRCCS

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported